emcardioНеотложная кардиология и кардиоваскулярные рискиEmergency Cardiology and Cardiovascular Risks journal2616-633XБелорусский государственный медицинский университетemcardio-277Research ArticleОригинальные научные публикацииOriginal Scientific ResearchОценка риска кардиохирургических вмешательств у пациентов со сниженной сократительной способностью миокарда. Часть 2. Маркеры миокардиального стресса и повреждения миокардаRisk stratification of cardiovascular interventions in patients with reduced myocardial contractility. Part2. Markers of myocardial stress and injuryШумовецВ. В.ShumavetsV. V.ПанкратовА. В.PankratovA. V.КолядкоМ. Г.KaljadkaM. G.ШибекоН. А.ShibekoN.ГринчукИ. И.GrinchukI. I.РусскихИ. И.RusskihI. I.ЛысенокЕ. Р.LysenokE. R.ОстровскийЮ. П.OstrovskiY. P.Республиканский научно-практический центр «Кардиология»Republic Scientific and Practical Centre «Cardiology»Белорусский государственный медицинский университетBelarus State Medical University20181311202522405412Copyright © Шумовец В.В., Панкратов А.В., Колядко М.Г., Шибеко Н.А., Гринчук И.И., Русских И.И., Лысенок Е.Р., Островский Ю.П., 20252025Шумовец В.В., Панкратов А.В., Колядко М.Г., Шибеко Н.А., Гринчук И.И., Русских И.И., Лысенок Е.Р., Островский Ю.П.Shumavets V.V., Pankratov A.V., Kaljadka M.G., Shibeko N., Grinchuk I.I., Russkih I.I., Lysenok E.R., Ostrovski Y.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://emcardio.bsmu.by/jour/article/view/277

Стратификация риска пациентов кардиохирургического профиля с хронической сердечной недостаточностью может быть уточнена с применением биомаркеров различных патофизиологических процессов. Цель: определение периоперационной динамики, закономерности и выявление прогностической ценностиновых кардиальных биомаркеров (миокардиального ремоделирования, миокардиального стресса, миокардиального повреждения и воспаления) у пациентов со сниженной сократительной способностью миокарда.

Background: Background: Background: Background: Background: Only clinical risk factors alone are used in current preoperative models estimating risk of hospital mortality following cardiac surgery. However, novel biomarkers such as Nterminal pro Btype natriuretic peptide (NTProBNP), high - sensitivity troponin I (hsTnI) or Galectin$3 potentially can improve the predictive ability and capacity to risk stratify patients before cardiac surgery. In this part we aimed to assess these novel biomarkers of cardiac remodeling and injury periope-ratively open heart surgery in patients with low ejection fraction.

аорто-коронарное шунтированиепластика митрального клапанахроническая сердечная недостаточностьмиокардиальные биомаркерыстратификация риска хирургического вмешательстваavascular necrosis of the bonemetabolic syndromeendothelial dysfunctionatherosclerosisbone turnoverosteoprotegerinReferencesMebazaa A., Pitsis A.A., Rudiger A., Toller W., Longrois D., Ricksten S.E., Bobek I., De Hert S., Wieselthaler G., Schirmer U., von Segesser L.K., Sander M., Poldermans D., Ranucci M., Karpati P.C., Wouters P., Seeberger M., Schmid E.R., Weder W., Follath F. Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery. Critical Care, 2010, vol. 14, № 2, pp. 201–215.Mebazaa A., Pitsis A.A., Rudiger A., Toller W., Longrois D., Ricksten S.E., Bobek I., De Hert S., Wieselthaler G., Schirmer U., von Segesser L.K., Sander M., Poldermans D., Ranucci M., Karpati P.C., Wouters P., Seeberger M., Schmid E.R., Weder W., Follath F. Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery. Critical Care, 2010, vol. 14, № 2, pp. 201–215.Nashef S.A., Roques F., Sharples L.D., Nilsson J., Smith C., Goldstone A.R., Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg, 2012, vol. 41, № 4, pp. 734–744.Nashef S.A., Roques F., Sharples L.D., Nilsson J., Smith C., Goldstone A.R., Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg, 2012, vol. 41, № 4, pp. 734–744.Lenz M., Krychtiuk K.A., Goliasch G., Distelmaier K., Wojta J., Heinz G., Speidl W.S. N-terminal pro-brain natriuretic peptide and high sensitivity troponin T exhibit additive prognostic value for the outcome of critically ill. Eur Heart J Acute Cardiovasc Care, 2018, Apr 1:2048872618768088. doi: 10.1177/2048872618768088.Lenz M., Krychtiuk K.A., Goliasch G., Distelmaier K., Wojta J., Heinz G., Speidl W.S. N-terminal pro-brain natriuretic peptide and high sensitivity troponin T exhibit additive prognostic value for the outcome of critically ill. Eur Heart J Acute Cardiovasc Care, 2018, Apr 1:2048872618768088. doi: 10.1177/2048872618768088.Braunwald E. Heart failure. JACC: Heart Fail, 2013, vol. 1, № 1, pp. 1–20. doi:10.1016/j.jchf.2012.10.002.Braunwald E. Heart failure. JACC: Heart Fail, 2013, vol. 1, № 1, pp. 1–20. doi:10.1016/j.jchf.2012.10.002.Taub P.R., Daniels L.B., Maisel L.S Usefulness of B-type natriuretic peptide levels in predicting hemodynamic and clinical decompensation. Heart Fail Clin. 2009, vol. 5, № 2, pp. 169–175. doi: 10.1016/j.hfc.2008.11.009.Taub P.R., Daniels L.B., Maisel L.S Usefulness of B-type natriuretic peptide levels in predicting hemodynamic and clinical decompensation. Heart Fail Clin. 2009, vol. 5, № 2, pp. 169–175. doi: 10.1016/j.hfc.2008.11.009.Januzzi J.L.Jr., Rehman S.U., Mohammed A.A., Bhardwaj A., Barajas L., Barajas J., Kim H.N., Baggish A.L., Weiner R.B., Chen-Tournoux A., Marshall J.E., Moore S.A., Carlson W.D., Lewis G.D., Shin J., Sullivan D., Parks K., Wang T.J., Gregory S.A., Uthamalingam S., Semigran M.J. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol, 2011, vol. 58, № 18, pp. 1881–1889.Januzzi J.L.Jr., Rehman S.U., Mohammed A.A., Bhardwaj A., Barajas L., Barajas J., Kim H.N., Baggish A.L., Weiner R.B., Chen-Tournoux A., Marshall J.E., Moore S.A., Carlson W.D., Lewis G.D., Shin J., Sullivan D., Parks K., Wang T.J., Gregory S.A., Uthamalingam S., Semigran M.J. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol, 2011, vol. 58, № 18, pp. 1881–1889.Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G.F., Coats A.J.S., Falk V., Gonz lez-Juanatey J.R., Harjola V.P., Jankowska E.A., Jessup M., Linde C., Nihoyannopoulos P., Parissis J.T., Pieske B., Riley J.P., Rosano G.M.C., Ruilope L.M., Ruschitzka F., Rutten F.H., van der Meer P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart. Eur Heart J, 2016, vol. 37, № 27, pp. 2129–2200.Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G.F., Coats A.J.S., Falk V., Gonz lez-Juanatey J.R., Harjola V.P., Jankowska E.A., Jessup M., Linde C., Nihoyannopoulos P., Parissis J.T., Pieske B., Riley J.P., Rosano G.M.C., Ruilope L.M., Ruschitzka F., Rutten F.H., van der Meer P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart. Eur Heart J, 2016, vol. 37, № 27, pp. 2129–2200.Maisel A., Mueller C., Adams K.Jr., Anker S.D., Aspromonte N., Cleland J.G., Cohen-Solal A., Dahlstrom U., DeMaria A., Di Somma S., Filippatos G.S., Fonarow G.C., Jourdain P., Komajda M., Liu P.P., McDonagh T., McDonald K., Mebazaa A., Nieminen M.S., Peacock W.F., Tubaro M., Valle R., Vander-hyden M., Yancy C.W., Zannad F., Braunwald E. State of the art: Using natriuretic peptide levels in clinical practice. Eur J Heart Fail, 2008, vol. 10, № 9, pp. 824–839.Maisel A., Mueller C., Adams K.Jr., Anker S.D., Aspromonte N., Cleland J.G., Cohen-Solal A., Dahlstrom U., DeMaria A., Di Somma S., Filippatos G.S., Fonarow G.C., Jourdain P., Komajda M., Liu P.P., McDonagh T., McDonald K., Mebazaa A., Nieminen M.S., Peacock W.F., Tubaro M., Valle R., Vander-hyden M., Yancy C.W., Zannad F., Braunwald E. State of the art: Using natriuretic peptide levels in clinical practice. Eur J Heart Fail, 2008, vol. 10, № 9, pp. 824–839.Karthikeyan G., Moncur R.A., Levine O., Heels-Ansdell D., Chan M.T., Alonso-Coello P., Yusuf S., Sessler D., Villar J.C., Berwanger O., McQueen M.,Mathew A., Hill S., Gibson S., Berry C., Yeh H.M., Devereaux P.J. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol, 2009, vol. 54, № 17, pp. 1599–1606.Karthikeyan G., Moncur R.A., Levine O., Heels-Ansdell D., Chan M.T., Alonso-Coello P., Yusuf S., Sessler D., Villar J.C., Berwanger O., McQueen M.,Mathew A., Hill S., Gibson S., Berry C., Yeh H.M., Devereaux P.J. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol, 2009, vol. 54, № 17, pp. 1599–1606.Rodseth R.N., Biccard B.M., Le Manach Y., Sessler D.I., Lurati Buse G.A., Thabane L., Schutt R.C., Bolliger D., Cagini L., Cardinale D., Chong C.P., Chu R., Cnotliwy M., Di Somma S., Fahrner R., Lim W.K., Mahla E., Manikandan R., Puma F., Pyun W.B., Radovi M., Rajagopalan S., Suttie S., Vanniyasingam T., van Gaal W.J., Waliszek M., Devereaux P.J. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol, 2014, vol. 63, № 2, pp.170–180.Rodseth R.N., Biccard B.M., Le Manach Y., Sessler D.I., Lurati Buse G.A., Thabane L., Schutt R.C., Bolliger D., Cagini L., Cardinale D., Chong C.P., Chu R., Cnotliwy M., Di Somma S., Fahrner R., Lim W.K., Mahla E., Manikandan R., Puma F., Pyun W.B., Radovi M., Rajagopalan S., Suttie S., Vanniyasingam T., van Gaal W.J., Waliszek M., Devereaux P.J. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol, 2014, vol. 63, № 2, pp.170–180.Polineni S., Parker D.M., Alam S.S., Thiessen-Philbrook H., McArthur E., DiScipio A.W., Malenka D.J., Parikh C.R, Garg A.X., Brown J.R. Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery. J Am Heart Assoc, 2018, vol. 7, № 4, pii: e008371. doi: 10.1161/JAHA.117.008371.Polineni S., Parker D.M., Alam S.S., Thiessen-Philbrook H., McArthur E., DiScipio A.W., Malenka D.J., Parikh C.R, Garg A.X., Brown J.R. Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery. J Am Heart Assoc, 2018, vol. 7, № 4, pii: e008371. doi: 10.1161/JAHA.117.008371.Thygesen K., Alpert J.S., Jaffe A.S., Chaitman B.R., Bax J.J., Morrow D.A., White H.D. Fourth universal definition of myocardial infarction. Eur Heart J, 2018, Aug 25. doi: 10.1093/eurheartj/ehy462.Thygesen K., Alpert J.S., Jaffe A.S., Chaitman B.R., Bax J.J., Morrow D.A., White H.D. Fourth universal definition of myocardial infarction. Eur Heart J, 2018, Aug 25. doi: 10.1093/eurheartj/ehy462.Baron J.M., Lewandrowski E.L., Januzzi J.L., Bajwa E.K., Thompson B.T., Lewandrowski K.B. Measurement of high-sensitivity troponin T in noncardiac medical intensive care unit patients. Correlation to mortality and length of stay. Am J Clin Pathol, 2014, vol. 141, № 4, pp. 488–493.Baron J.M., Lewandrowski E.L., Januzzi J.L., Bajwa E.K., Thompson B.T., Lewandrowski K.B. Measurement of high-sensitivity troponin T in noncardiac medical intensive care unit patients. Correlation to mortality and length of stay. Am J Clin Pathol, 2014, vol. 141, № 4, pp. 488–493.] Brown J.R., Jacobs J.P., Alam S.S., Thiessen Philbrook H., Everett A., Likosky D.S., Lobdell K., Wyler von Ballmoos M.C., Parker D.M., Garg A.X., Mackenzie T., Jacobs M.L., Parikh C.R. Utility of Biomarkers to Improve Prediction of Readmission or Mortality After Cardiac Surgery. Ann Thorac Surg, 2018, Aug 4, pii: S0003 4975(18)31058 0. doi: 10.1016/ j.athoracsur.2018.06.052.] Brown J.R., Jacobs J.P., Alam S.S., Thiessen Philbrook H., Everett A., Likosky D.S., Lobdell K., Wyler von Ballmoos M.C., Parker D.M., Garg A.X., Mackenzie T., Jacobs M.L., Parikh C.R. Utility of Biomarkers to Improve Prediction of Readmission or Mortality After Cardiac Surgery. Ann Thorac Surg, 2018, Aug 4, pii: S0003 4975(18)31058 0. doi: 10.1016/ j.athoracsur.2018.06.052.Shen J.T., Xu M., Wu Y., Wen S.H., Li X., Zhao B.C., Huang W.Q. Association of pre-operative troponin levels with major adverse cardiac events and mortality after noncardiac surgery: A systematic review and meta-analysis. Eur J Anaesthesiol, 2018, vol. 35, № 11, pp. 815–824.Shen J.T., Xu M., Wu Y., Wen S.H., Li X., Zhao B.C., Huang W.Q. Association of pre-operative troponin levels with major adverse cardiac events and mortality after noncardiac surgery: A systematic review and meta-analysis. Eur J Anaesthesiol, 2018, vol. 35, № 11, pp. 815–824.Norusis M. SPSS 13.0 Guide to Data Analysis. Upper Saddle River, N.J.: Prentice Hall, Inc, 2004, pp. 134.Norusis M. SPSS 13.0 Guide to Data Analysis. Upper Saddle River, N.J.: Prentice Hall, Inc, 2004, pp. 134.Glantz S.A. Primer of Biostatistics. New York [etc]: McGrawHill Medical, 1994. (Russ. ed.: Danilov Yu.A., Buzikashvili N.E., Samoylov D.V. Medikobiologicheskaya statistika. Moscow: Praktika , 1999. 119 p.).Glantz S.A. Primer of Biostatistics. New York [etc]: McGrawHill Medical, 1994. (Russ. ed.: Danilov Yu.A., Buzikashvili N.E., Samoylov D.V. Medikobiologicheskaya statistika. Moscow: Praktika , 1999. 119 p.).

The authors declare that there are no conflicts of interest present.